We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Debiopharm to Acquire Affinium’s Antibiotic Clinical Assets and Platform

News   Feb 12, 2014

 
Debiopharm to Acquire Affinium’s Antibiotic Clinical Assets and Platform
 
 
Advertisement
 

RELATED ARTICLES

COVID-19 Could Outwit Science Unless Knowledge Stays Current

News

The virus that causes COVID-19 has many variants, and if scientists don’t stay on top of how it is changing in different parts of the world, testing for it may produce false negative results.

READ MORE

Metabolomics Meets Genomics To Improve Patient Diagnosis

News

Researchers from Baylor College of Medicine have integrated whole-exome sequencing and targeted metabolomics to analyze the data of a group of 170 patients. They were pleased to find that the metabolomics data informed 44 percent of the cases.

READ MORE

Team Synthesizes Safer Nonaddictive Analgesics

News

A team has discovered a new class of drugs, capable of relieving pain and reducing fever without the danger of addiction or damage to the liver or kidneys.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE